Trigeminal Nerve Diseases (Trigeminal Nerve Disorders)

Subscribe to Selected New Research on Trigeminal Nerve Diseases

41 relevant articles (2 outcomes, 2 trials/studies) found for this Disease

Description: Diseases of the trigeminal nerve or its nuclei, which are located in the pons and medulla. The nerve is composed of three divisions: ophthalmic, maxillary, and mandibular, which provide sensory innervation to structures of the face, sinuses, and portions of the cranial vault. The mandibular nerve also innervates muscles of mastication. Clinical features include loss of facial and intra-oral sensation and weakness of jaw closure. Common conditions affecting the nerve include brain stem ischemia, INFRATENTORIAL NEOPLASMS, and TRIGEMINAL NEURALGIA.

Also Known As:

Trigeminal Nerve Disorders; Trigeminal Neuropathy; Trigeminal Neuropathy, Idiopathic; Idiopathic Trigeminal Neuropathies; Idiopathic Trigeminal Neuropathy; Neuropathies, Idiopathic Trigeminal; Neuropathies, Trigeminal; Neuropathy, Idiopathic Trigeminal; Neuropathy, Trigeminal; Syndrome, Raeder Paratrigeminal; Trigeminal Nerve Disease; Trigeminal Nerve Disorder; Trigeminal Neuropathies; Trigeminal Neuropathies, Idiopathic; Cranial Nerve V Diseases; Fifth Cranial Nerve Diseases; Raeder Paratrigeminal Syndrome

Relationship Network

Disease Context: Research Results

Nervous System Diseases: 3406

Cranial Nerve Diseases: 147

Trigeminal Nerve Diseases: 41

Trigeminal Neuralgia: 1204

Related Diseases

1.	Pain (Aches)
2.	Syndrome
3.	Neuralgia (Stump Neuralgia)
4.	Postherpetic Neuralgia
5.	Spinal Cord Injuries (Spinal Cord Injury)

Experts

1.	Plaza-Costa, Andrés: 1 article (07/2007)
2.	de Entrambasaguas, Manuel: 1 article (07/2007)
3.	Casal, Joaquín: 1 article (07/2007)
4.	Parra, Silvia: 1 article (07/2007)
5.	Benoliel, Rafael: 1 article (01/2007)
6.	Eliav, Eli: 1 article (01/2007)
7.	Sharav, Yair: 1 article (01/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Trigeminal Nerve Diseases:

1.	Capsaicin (Zostrix)IBA 12/01/1994 - "The efficacy of repeated nasal applications of capsaicin in cluster headache is congruent with previous reports on the therapeutic effect of capsaicin in other pain syndromes (post-herpetic neuralgia, diabetic neuropathy, trigeminal neuralgia) and supports the use of the drug to produce a selective analgesia." Order ALL the reference details at left...
2.	Protons (Proton)IBA 09/01/2002 - "This study, prompted by reports of transient (30% each) and permanent (10% each) facial and trigeminal neuropathy after stereotactic radiosurgery of vestibular schwannomas with marginal doses of 16-20 Gy, assessed whether proton beam radiosurgery using a marginal dose of only 12 Gy could control vestibular schwannomas while causing less neuropathy" Order ALL the reference details at left...
3.	Lorazepam (Ativan)FDA LinkGeneric 10/10/2000 - "METHODS: A randomized, double-blind, crossover trial compared 6 weeks of oral dextromethorphan with active placebo (low-dose lorazepam) in 19 patients, stratified into three groups: 11 with facial pain and possible trigeminal neuropathy, five with anesthesia dolorosa, and three with idiopathic trigeminal neuralgia" Order ALL the reference details at left...
4.	Dextromethorphan (Levomethorphan)FDA LinkGeneric 10/10/2000 - "CONCLUSIONS: Dextromethorphan shows little or no analgesic efficacy in pain due to possible trigeminal neuropathy and anesthesia dolorosa" 10/10/2000 - "In patients with possible trigeminal neuropathy and anesthesia dolorosa, dextromethorphan decreased pain by a mean of only 2 to 4%, and these estimates were not significant" 10/10/2000 - "METHODS: A randomized, double-blind, crossover trial compared 6 weeks of oral dextromethorphan with active placebo (low-dose lorazepam) in 19 patients, stratified into three groups: 11 with facial pain and possible trigeminal neuropathy, five with anesthesia dolorosa, and three with idiopathic trigeminal neuralgia" Order ALL the reference details at left...
5.	EVAC protocol (CAVE)IBA 01/01/1999 - "Among nine patients with new trigeminal neuropathy, six received doses of more than 19 Gy to Meckel's cave" 01/01/1992 - "The second patient had a sensorimotor trigeminal neuropathy caused by a direct compression of the semilunar ganglion by a cavernous hemangioma of Meckel's cave" 07/01/1995 - "Trigeminal neuropathy arising from the Meckel cave and cavernous sinus is frequently due to meningiomas, trigeminal schwannomas, epidermoid cysts, metastases, pituitary adenomas, and aneurysms" Order ALL the reference details at left...
6.	dichloroacetyleneIBA 01/01/1993 - "Dichloroacetylene causes trigeminal neuropathy in humans and animals" 01/01/1992 - "Furthermore, the effects of Tce and of dichloroacetylene (Dca), a breakdown product supposed to be the main cause of the trigeminal neuropathy, were compared under the same experimental conditions" 01/01/1981 - "Human cases of intoxication have been associated with trigeminal neuropathy, however this is probably caused by a breakdown product dichloroacetylene" Order ALL the reference details at left...
7.	RibonucleoproteinsIBA 12/01/1978 - "Raynaud phenomenon occurred almost synchronously with the onset of trigeminal neuropathy and was followed by myositis, diffuse hand swelling, synovitis, and increased ribonucleoprotein antibody" 07/01/1982 - "Serum antibodies to ribonucleoprotein were identified in nine (45 percent) of 20 PSS patients with trigeminal neuropathy as compared to 25 (8 percent) of 329 PSS patients without trigeminal neuropathy" Order ALL the reference details at left...
8.	AntibodiesIBA 07/01/1982 - "Serum antibodies to ribonucleoprotein were identified in nine (45 percent) of 20 PSS patients with trigeminal neuropathy as compared to 25 (8 percent) of 329 PSS patients without trigeminal neuropathy" 01/01/1994 - "The levels of antibodies to bacterial (tuberculin, staphylococcus, pneumococcus, streptococcus) and viral (herpes, measles, rubella, parotiditis, influenza) antigens were determined in 39 patients with trigeminal neuralgia (TN) aggravation of which 25 were untreated, while 14 had received a course of the cadaveric nerve specific tissue therapy, 46 healthy subjects and 31 patients with trigeminal neuropathy served control" Order ALL the reference details at left...
9.	Oligoclonal BandsIBA 03/01/2008 - "CASE REPORT: A 41-year-old man developed a right cochleovestibular and left trigeminal neuropathy, associated with high serum titers of VDRL and TPHA, high titers of TPHA in the cerebrospinal fluid (CSF) and several CSF oligoclonal IgG bands" Order ALL the reference details at left...
10.	Gadolinium DTPA (Magnevist)FDA Link 07/01/1991 - "Trigeminal neuropathy: Gd-DTPA enhanced MR imaging." Order ALL the reference details at left...

Therapies and Procedures

1.	Anesthesia 10/10/2000 - "RESULTS: Patients completing the trial included 10 with possible trigeminal neuropathy, four with anesthesia dolorosa, and two with trigeminal neuralgia" 03/01/2000 - "Trigeminal neuropathy with nasal ulceration, called trigeminal trophic syndrome, is an unusual complication of anesthesia in the trigeminal area" 11/15/1991 - "Two previous cases of cold-induced corneal edema have been reported in patients with corneal anesthesia secondary to a trigeminal nerve disorder" 06/01/1989 - "Unilateral corneal anesthesia (or hypesthesia) caused by trigeminal nerve disease has an unknown effect on the Schirmer test" 01/01/2001 - "Epidural MCS is effective for trigeminal neuropathy, lateral medullary and thalamic infarction, anesthesia dolorosa, postherpetic neuralgia, spinal cord injury, and limb stump pain" Order ALL the reference details at left...
2.	Analgesia 12/01/1994 - "The efficacy of repeated nasal applications of capsaicin in cluster headache is congruent with previous reports on the therapeutic effect of capsaicin in other pain syndromes (post-herpetic neuralgia, diabetic neuropathy, trigeminal neuralgia) and supports the use of the drug to produce a selective analgesia." Order ALL the reference details at left...
3.	Decompression 10/01/1980 - "In cases of persistent idiopathic trigeminal neuropathy with or without intractable pain, retromastoid craniectomy with microvascular decompression of the 5th nerve is a therapeutic alternative" 01/01/1999 - "Irradiation-associated adverse effects (18%) comprised neurological signs (incomplete facial palsy, four cases (two recovered completely), and mild trigeminal neuropathy, three cases, respectively) and morphological changes (three patients) marked by an enlargement of pre-existing cystic components calling for additional surgical treatment: Microsurgical decompression was performed in two cases, the third patient underwent a shunting procedure because of hydrocephalus formation" 12/01/2006 - "RESULTS: Radiofrequency rhizotomy was performed in 273 patients with idiopathic trigeminal neuralgia and in all other patients, except for trigeminal neuropathy; neurovascular decompression was performed in 18 idiopathic trigeminal neuralgia patients; 100% idiopathic trigeminal neuralgia, 96.2% symptomatic trigeminal neuralgia, 37.5% atypical facial pain and 88.9% post-herpetic neuralgia had pain relief" Order ALL the reference details at left...
4.	Amputation 06/01/2008 - "METHODS: Eighteen neuropathic pain patients (central stroke in six; trigeminal neuropathy in six; syrinx or amputation in six) who underwent operations for epidural MCS were studied with preoperative fMRI and iCM" 04/01/2005 - "METHODS: Eighteen neuropathic pain patients (central stroke in six; trigeminal neuropathy in six; syrinx or amputation in six) who underwent operations for epidural MCS were studied with preoperative fMRI and iCM" 10/01/2005 - "METHODS: Twenty-one patients (11 women and 10 men; mean age, 55.6 years) with refractory central (ischemic, 8 cases) and neuropathic pain (trigeminal neuropathy, 6 cases; syrinx/amputation/plexus trauma, 7 cases) underwent surgery for the implantation of an epidural electrode for chronic motor cortex stimulation (MCS) with general anesthesia and a frameless neuronavigation system used for the image-guided targeting procedure" Order ALL the reference details at left...
5.	Aftercare (After-Treatment) 01/01/1999 - "There was new transient facial weakness in five patients(23%), and there was new trigeminal neuropathy after treatment in one patient (4.8%)" 04/01/1992 - "New delayed facial or trigeminal neuropathy occurred in 34% and 32% of patients, respectively, with a median onset of 5 to 6 months after treatment" 11/01/2006 - "Multivariate and actuarial statistics were used to analyze rates of local tumor control and complications, including facial and trigeminal neuropathies, after treatment" Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Trigeminal Nerve Diseases

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 2 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>